Our molecular epidemiology research program is focused on epigenetic states across the continuum from normal cellular states to pre-invasive, and invasive cancers. Our goals include advancing the understanding of how risk factors for cancers including aging and exposures are related with DNA methylation alterations in normal tissues, as well as identifying patterns of DNA methylation in tumors that are related with patient outcomes.